Dermalogica simply introduced the U.S. Meals and Drug Administration (FDA) has granted them clearance for the PRO Pen Microneedling System as a Class II medical system. This new authorization comes after a rigorous regulatory course of and a number of medical research. In the end, it should enable the corporate to market and distribute the PRO Pen Microneedling System within the U.S. starting in 2026.
Dermalogica PRO Secures FDA 510(ok) Clearance for Subsequent-Technology PRO Pen Microneedling System, Ushering in a New Period of Pores and skin Well being Innovation
The Dermalogica PRO Pen Microneedling System was designed with each sufferers and practitioners in thoughts and has the facility to improve and elevate in-office remedy outcomes. Vice-president of Know-how & Innovation, Dr. Robert J. Bianchini, notes that this up to date design marks a milestone growth into medical spas, following within the footsteps of the model’s Exobooster Lactobacillus Exosome Remedy Serum.
“As consumer preference rises for less invasive, evidence-backed treatments and in-office solutions that deliver results without compromise, the PRO Pen Microneedling System positions Dermalogica at the forefront of next-generation medical aesthetics,” notes the model in its press launch.
“Dermalogica has all the time superior pores and skin well being, however FDA clearance marks our evolution into a brand new enviornment as a medical system innovator. By shifting past conventional skincare and bringing our innovation mindset into medical aesthetics, we’re not simply celebrating a model milestone—we’re elevating the bar for all the business with remedies practitioners are proud to ship and customers can actually belief,” says Govt Officer Aurelian Lis. The model hopes to proceed to bridge the hole between pores and skin well being and medical aesthetics by equipping professionals with superior instruments and schooling.
